Global Recombinant Protein Drugs Market Status and Outlook 2018-2025

July 2018 | 121 pages | ID: G7199C12AADEN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Novo Nordisk
• Amgen
• Sanofi
• Eli Lilly
• Merck Serono
• Ortho Biotech
• Roche
• Kyowa Hakko Kirin
• Pharmingen
• Abcam
• GenSci
• SL PHARM
• Dongbao Pharm
• Ankebio
• NCPC
• Heng Rui

Market by Type

• Recombinant DNA
• Recombinant RNA

Market by Application

• Pharmaceutical Industry
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Recombinant Protein Drugs Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Recombinant DNA
  3.1.2 Recombinant RNA
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Pharmaceutical Industry
  4.1.2 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Recombinant DNA Production by Region
    6.1.1.2 Recombinant RNA Production by Region
  6.1.2 Production by Application
    6.1.2.1 Pharmaceutical Industry Production by Region
    6.1.2.2 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Recombinant DNA Demand by Region
    6.2.1.2 Recombinant RNA Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Pharmaceutical Industry Demand by Region
    6.2.2.2 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Novo Nordisk
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Amgen
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Sanofi
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Eli Lilly
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Merck Serono
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Ortho Biotech
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Roche
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Kyowa Hakko Kirin
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Pharmingen
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Abcam
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 GenSci
8.12 SL PHARM
8.13 Dongbao Pharm
8.14 Ankebio
8.15 NCPC
8.16 Heng Rui

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Recombinant Protein Drugs Industry Dynamics & Regulations List
Table Global Recombinant Protein Drugs Sales Revenue, Cost and Margin, 2015-2018E
Table Global Recombinant Protein Drugs Market Status by Type 2015-2018E, in USD Million
Table Global Recombinant Protein Drugs Market Status by Application 2015-2018E, in USD Million
Table Global Recombinant Protein Drugs Market Status by Application 2015-2018E, in Volume
Table Global Recombinant Protein Drugs Market by Region 2015-2018E, in USD Million
Table Global Recombinant Protein Drugs Market Share by Region in 2018, in USD Million
Table Global Recombinant Protein Drugs Market by Region 2015-2018E, in Volume
Table Global Recombinant Protein Drugs Market Share by Region in 2018, in Volume
Table Recombinant DNA Production Value by Region 2015-2018E, in USD Million
Table Recombinant DNA Production Volume by Region 2015-2018E, in Volume
Table Recombinant RNA Production Value by Region 2015-2018E, in USD Million
Table Recombinant RNA Production Volume by Region 2015-2018E, in Volume
Table Pharmaceutical Industry Production Value by Region 2015-2018E, in USD Million
Table Pharmaceutical Industry Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Recombinant DNA Market Size by Region 2015-2018E, in USD Million
Table Recombinant DNA Market Size by Region 2015-2018E, in Volume
Table Recombinant RNA Market Size by Region 2015-2018E, in USD Million
Table Recombinant RNA Market Size by Region 2015-2018E, in Volume
Table Pharmaceutical Industry Market Size by Region 2015-2018E, in USD Million
Table Pharmaceutical Industry Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalRecombinant Protein Drugs Forecast by Type 2019F-2025F, in USD Million
Table Recombinant Protein Drugs Forecast by Type 2019F-2025F, in Volume
Table Recombinant Protein Drugs Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Recombinant Protein Drugs Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Recombinant Protein Drugs Market Forecast by Region 2019F-2025F, in USD Million
Table Recombinant Protein Drugs Market Forecast by Region 2019F-2025F, in Volume
Table Novo Nordisk Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Novo Nordisk
Table Amgen Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Amgen
Table Sanofi Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Sanofi
Table Eli Lilly Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Eli Lilly
Table Merck Serono Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Merck Serono
Table Ortho Biotech Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Ortho Biotech
Table Roche Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Roche
Table Kyowa Hakko Kirin Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Kyowa Hakko Kirin
Table Pharmingen Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Pharmingen
Table Abcam Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Abcam
Table GenSci Information
Table Recombinant Protein Drugs Sales, Cost, Margin of GenSci
Table SL PHARM Information
Table Recombinant Protein Drugs Sales, Cost, Margin of SL PHARM
Table Dongbao Pharm Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Dongbao Pharm
Table Ankebio Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Ankebio
Table NCPC Information
Table Recombinant Protein Drugs Sales, Cost, Margin of NCPC
Table Heng Rui Information
Table Recombinant Protein Drugs Sales, Cost, Margin of Heng Rui
Table Global Recombinant Protein Drugs Sales Revenue by Company 2015-2017, in USD Million
Table Global Recombinant Protein Drugs Sales Volume by Company 2015-2017, in Volume
Table Global Recombinant Protein Drugs Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Recombinant Protein Drugs Picture
Figure Recombinant Protein Drugs Industry Chain Diagram
Figure Global Recombinant Protein Drugs Sales Revenue 2015-2018E, in USD Million
Figure Global Recombinant Protein Drugs Sales Volume 2015-2018E, in Volume
Figure Global Recombinant Protein Drugs Market Status by Type 2015-2018E, in Volume
Figure North America Recombinant Protein Drugs Market Size and Growth 2015-2018E, in USD Million
Figure North America Recombinant Protein Drugs Market Size and Growth 2015-2018E, in Volume
Figure Europe Recombinant Protein Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Europe Recombinant Protein Drugs Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Recombinant Protein Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Recombinant Protein Drugs Market Size and Growth 2015-2018E, in Volume
Figure South America Recombinant Protein Drugs Market Size and Growth 2015-2018E, in USD Million
Figure South America Recombinant Protein Drugs Market Size and Growth 2015-2018E, in Volume
Figure Middle East Recombinant Protein Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Recombinant Protein Drugs Market Size and Growth 2015-2018E, in Volume
Figure Africa Recombinant Protein Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Africa Recombinant Protein Drugs Market Size and Growth 2015-2018E, in Volume
Figure Global Recombinant Protein Drugs Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Recombinant Protein Drugs Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Recombinant Protein Drugs Sales Price Forecast 2019F-2025F
Figure Global Recombinant Protein Drugs Gross Margin Forecast 2019F-2025F
Figure Global Recombinant Protein Drugs Sales Revenue by Company in 2018, in USD Million
Figure Global Recombinant Protein Drugs Price by Company in 2018
Figure Global Recombinant Protein Drugs Gross Margin by Company in 2018